摘要
目的:系统评价疏肝健脾中药治疗肝郁脾虚型失眠的有效性及安全性。方法:计算机检索中国知网(CNKI)、维普中文科技期刊(VIP)、万方数字化期刊(Wanfang Data)、PubMed数据库和Web of Science,检索时间范围为建库至2020年1月,按纳入标准和排除标准筛选文献,纳入文献后进行质量评价和资料提取,采用RevMan 3.5统计软件进行Meta分析。结果:纳入文献11篇,共872例患者,依据Cochrane协作网系统评价方法进行评价,使用RevMan5.3进行Meta分析。疏肝健脾中药治疗失眠的有效率高于常规治疗,差异有统计学意义(P<0.05);疏肝健脾中药治疗失眠肝郁脾虚型的不良反应较常规治疗低,差异有统计学意义(P<0.05)。结论:疏肝健脾中药治疗失眠的有效率和安全性均高于常规治疗。
Objective:To evaluate the efficacy and safety of the Shugan Jianpi prescriptions(疏肝健脾中药)on insomnia of the Ganyu Pixu type(肝郁脾虚型).Methods:CNKI,VIP,Wanfang Data,PubMed database and Web of Science were searched by computer.The retrieval time was from the establishment of the database to January 2020.The literature was selected according to the inclusion criteria and exclusion criteria.After the literature was included,the quality evaluation and data extraction were carried out.The Metaanalysis was carried out by Revman 3.5 statistical software.Results:872 patients were included in 11 literatures,and were evaluated according to Cochrane collaborative network system evaluation method.Finally,Revman 5.3 was used for Meta analysis.The efficiency of the Shugan Jianpi prescriptions on insomnia was higher than that of routine treatment(P<0.05).The adverse reactions of the Shugan Jianpi prescriptions on insomnia of the Ganyu Pixu type were lower than the routine treatment(P<0.05).Conclusion:The efficacy and safety of the Shugan Jianpi prescriptions on insomnia are higher than that of conventional treatment.
出处
《中医临床研究》
2020年第35期133-137,共5页
Clinical Journal Of Chinese Medicine
